Professor Melief to receive 2022 SITC Pedro J. Romero Award

ISA Pharmaceuticals’ Chief Scientific Officer Prof. Dr. Melief Awarded Fellowship at the Society for Immunotherapy of Cancer

ISA to Present at Business Conferences in May 2022

ISA Pharmaceuticals announces the start of clinical trial using its novel AMPLIVANT® technology

Long term study confirms efficacy of our T-cell activating immunotherapy in combination with checkpoint inhibitor

ISA Pharmaceuticals to Attend Multiple In Person Conferences in Early 2022